Anti-CD45RA/ PTPRC isoform RA monoclonal antibody

Anti-CD45RA/PTPRC isoform RA antibody for FACS & in-vivo assay


Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T43115-8-Ab-1/ GM-Tg-hg-T43115-8-Ab-2 Anti-Human CD45RA monoclonal antibody Human
GM-Tg-hg-T43115-8-Ab-3/ GM-Tg-hg-T43115-8-Ab-4 Anti-Human CD45RA monoclonal antibody Human
GM-Tg-rg-T43115-8-Ab-1/ GM-Tg-rg-T43115-8-Ab-2 Anti-Rat CD45RA monoclonal antibody Rat
GM-Tg-mg-T43115-8-Ab-1/ GM-Tg-mg-T43115-8-Ab-2 Anti-Mouse CD45RA monoclonal antibody Mouse
GM-Tg-cynog-T43115-8-Ab-1/ GM-Tg-cynog-T43115-8-Ab-2 Anti-Cynomolgus/ Rhesus macaque CD45RA monoclonal antibody Cynomolgus/ Rhesus macaque
GM-Tg-felg-T43115-8-Ab-1/ GM-Tg-felg-T43115-8-Ab-2 Anti-Feline CD45RA monoclonal antibody Feline
GM-Tg-cang-T43115-8-Ab-1/ GM-Tg-cang-T43115-8-Ab-2 Anti-Canine CD45RA monoclonal antibody Canine
GM-Tg-bovg-T43115-8-Ab-1/ GM-Tg-bovg-T43115-8-Ab-2 Anti-Bovine CD45RA monoclonal antibody Bovine
GM-Tg-equg-T43115-8-Ab-1/ GM-Tg-equg-T43115-8-Ab-2 Anti-Equine CD45RA monoclonal antibody Equine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T43115-8-Ab-1/ GM-Tg-hg-T43115-8-Ab-2; GM-Tg-hg-T43115-8-Ab-3/ GM-Tg-hg-T43115-8-Ab-4; GM-Tg-rg-T43115-8-Ab-1/ GM-Tg-rg-T43115-8-Ab-2;
GM-Tg-mg-T43115-8-Ab-1/ GM-Tg-mg-T43115-8-Ab-2; GM-Tg-cynog-T43115-8-Ab-1/ GM-Tg-cynog-T43115-8-Ab-2;
GM-Tg-felg-T43115-8-Ab-1/ GM-Tg-felg-T43115-8-Ab-2; GM-Tg-cang-T43115-8-Ab-1/ GM-Tg-cang-T43115-8-Ab-2;
GM-Tg-bovg-T43115-8-Ab-1/ GM-Tg-bovg-T43115-8-Ab-2; GM-Tg-equg-T43115-8-Ab-1/ GM-Tg-equg-T43115-8-Ab-2
Products Name Anti-CD45RA monoclonal antibody
Format mab
Target Name CD45RA
Protein Sub-location Transmembrane Protein
Category of antibody FACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species) Mouse/Human
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC) N/A
Expression platform Mammalian Expression
Bioactivity validation Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
Tag Fc
Products description Pre-made anti-CD45RA benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Biosimilar GMP-Bios-ab-029 Pre-Made Apamistamab biosimilar, Whole mAb Radiolabelled, Anti-CD45RA Antibody: Anti-B220/CD45/GP180/L-CA/LCA/LY5/T200 therapeutic antibody
    Biosimilar GMP-Bios-INN-875 Pre-Made Iodine (131I) Apamistamab Biosimilar, Radiolabelled Antibody, Anti-CD45RA Antibody: Anti-B220/CD45/GP180/L-CA/LCA/LY5/T200 therapeutic antibody


    Target information

    Target ID GM-T43115-8
    Target Name CD45RA
    Gene ID 1957
    Gene Symbol and Synonyms CD45RA, LCA-RB, T200, PTPRC isoform RA, Leukocyte common antigen RA
    Uniprot Accession P08575
    Uniprot Entry Name CD45R_HUMAN
    Protein Sub-location Transmembrane Protein (Leukocyte surface antigen)
    Category Therapeutic Target, Immune Checkpoint
    Disease Acute Myeloid Leukemia (AML), Autoimmune Diseases, Transplant Rejection
    Gene Ensembl ENSG00000170361
    Target Classification Leukocyte differentiation marker, Immune Receptor Modulator


    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM's Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.